Basit öğe kaydını göster

dc.contributor.authorMerkel, B.
dc.contributor.authorJokubaitis, V.
dc.contributor.authorSpelman, T.
dc.contributor.authorHorakova, D.
dc.contributor.authorHavrdova, E.
dc.contributor.authorTrojano, M.
dc.contributor.authorSpitaleri, D.
dc.date.accessioned2020-06-21T13:18:13Z
dc.date.available2020-06-21T13:18:13Z
dc.date.issued2017
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.urihttps://hdl.handle.net/20.500.12712/12225
dc.description7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) -- OCT 25-28, 2017 -- Paris, FRANCEen_US
dc.descriptionFerraro, Diana/0000-0003-4818-3806; Ramo-Tello, Cristina M/0000-0001-8643-5053; Lugaresi, Alessandra/0000-0003-2902-5589; McCombe, Pamela/0000-0003-2704-8517en_US
dc.descriptionWOS: 000413730200109en_US
dc.description.abstracten_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosisen_US
dc.description.sponsorshipUK MS Society; NHMRCNational Health and Medical Research Council of Australia; University of MelbourneUniversity of Melbourneen_US
dc.description.sponsorshipThis project was funded by the UK MS Society, NHMRC and University of Melbourne.en_US
dc.language.isoengen_US
dc.publisherSage Publications Ltden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleTiming of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosisen_US
dc.typeconferenceObjecten_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume23en_US
dc.identifier.startpage71en_US
dc.identifier.endpage73en_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster